Melanopic Light and ICU Delirium: Mechanisms and Clinical Evidence

Delirium is a common and serious complication in intensive care units (ICUs), often linked with disrupted circadian rhythms and sleep-wake cycles. ¹ ICU patients are frequently exposed to continuous artificial lighting and other environmental stressors that can disturb their normal day-night cycle ².

Intrinsically photosensitive retinal ganglion cells (ipRGCs) in the eye, containing the photopigment melanopsin, play a key role in regulating circadian rhythms. These cells are most sensitive to blue light (~480 nm) and convey environmental light information to the brain's master clock in the suprachiasmatic nucleus (SCN) and to the pineal gland, which controls melatonin secretion. ³⁴

Under normal conditions, darkness at night stimulates melatonin release (peaking in the early morning hours), whereas exposure to strong light – especially blue-enriched light – suppresses melatonin production. ⁵

This light-driven alignment of circadian hormones helps maintain normal sleep-wake patterns. In the ICU, however, patients often experience circadian dysregulation: blunted day-night light contrasts, noise, and caregiving interruptions that alter melatonin and cortisol rhythms. ⁶⁷

Such circadian disruption is increasingly recognized as a contributing factor to ICU delirium. ⁸

Understanding the Science First

Given this mechanistic backdrop, there is growing interest in melanopic light interventions – i.e. tailored blue-enriched lighting strategies – to reduce ICU delirium by restoring more normal circadian cues. Below, we review recent evidence (primarily from the past decade) on how stimulating ipRGC pathways with blue-enriched light, or conversely minimizing nocturnal blue light, affects delirium incidence and recovery in critical and acute care settings.

Mechanistic Links Between Light, Circadian Rhythms, and Delirium

ipRGC Activation and Circadian Regulation

ipRGCs respond strongly to blue-spectrum light and send signals to the SCN, aligning the body's internal clock with the external light-dark cycle. Through this pathway, daytime blue-enriched light promotes wakefulness and suppresses the "hormone of darkness," melatonin. At night, the absence of blue light allows melatonin to rise, facilitating sleep.

In healthy individuals, this robust melatonin rhythm helps maintain normal sleep architecture and cognition. In ICU patients, studies have documented that those who develop delirium often lose the normal circadian pattern of melatonin and cortisol secretion, whereas non-delirious patients maintain more robust rhythms. ⁹ In one prospective ICU study, delirious patients showed flat or arrhythmic melatonin/cortisol levels over 24 hours, in contrast to clear day-night hormonal cycles in non-delirious patients. ¹⁰

These findings suggest that circadian hormone disturbance is associated with delirium development. Indeed, sleep-wake cycle disturbances (while not a formal diagnostic criterion) are present in roughly 75% of delirious ICU patients. ¹¹Light is the principal environmental cue for circadian entrainment, so manipulating light exposure in the ICU – increasing daytime melanopic (blue-enriched) illumination and reducing nocturnal light – is a logical strategy to support circadian alignment.

Nocturnal Light and Sleep

Blue-rich light at night is particularly problematic, as even low levels can suppress melatonin and fragment sleep. Typical hospital lighting has abundant blue wavelengths, which can cause unwanted circadian stimulation during overnight hours. Small quality-improvement studies have trialed "blue-depleted" lighting at night (using amber-hued illumination) to minimize ipRGC activation after dark.

This concept complements daytime interventions: bright, blue-enriched light during the day to stimulate alertness, and darkness or blue-filtered light at night to allow restorative sleep.

Both aspects are likely important for optimizing circadian function and potentially reducing delirium.

Clinical Studies in ICUs: Light Exposure and Delirium Outcomes

Research in ICU environments has tested whether modifying light exposure can reduce delirium. These studies range from observational analyses of natural light to interventional trials of artificial lighting systems.

Natural Daylight Exposure

Being in an ICU room with a window (and thus natural light cycles) appears to lower delirium risk compared to windowless rooms. A 2022 study in a medical ICU compared patients in rooms with vs. without windows.¹² Delirium incidence was significantly lower for patients with natural light exposure (21.7%) than for those in windowless rooms (43.3%). In fact, admission to a windowed room was an independent predictor of reduced delirium risk (adjusted OR ~0.32).

No differences were observed in other outcomes like length of stay, but this finding suggests that sunlight and a visible day-night cycle can be protective against ICU delirium.

These results align with earlier observations that ICU relocations to units with more windows or higher daytime light intensity are associated with shorter delirium duration. They reinforce the importance of architectural design: maximizing natural light in ICUs (and by extension, the melanopic stimulation during daytime) may help maintain patients' circadian rhythms and mental status.

Dynamic Lighting Systems in ICUs

Recognizing that many ICU rooms lack adequate natural light, investigators have explored artificial dynamic lighting to simulate a normal circadian cycle. In dynamic lighting, overhead fixtures automatically vary in intensity and color temperature over 24 hours (bright, blue-enriched light during daytime; dim, warmer (lower blue) light in evening/night).

Mixed Results from Major RCT

One of the largest trials of this approach was a single-center randomized controlled trial by Simons et al. (2016). ¹³ They enrolled 734 ICU patients to receive either a dynamic light intervention(peaking at ~1700 lux and 4300 K color temperature during morning and afternoon hours, with lights off at night) or standard ICU lighting (~300 lux constant, with usual care). Importantly, both groups had identical lighting hardware; only the automated light schedule differed.

The primary outcome was ICU delirium incidence. The result: no significant difference in delirium occurrence betweenthe dynamic-light group (38% incidence) and standard-light group (33%). Delirium duration and other secondary outcomes were likewise no different. Despite successfully achieving higher daytime light levels (on average ~5,366 lux vs 2,793 lux in controls), the intervention did not reduce delirium.

The authors concluded that supranormal dynamic lighting conferred no apparent benefit over normal lighting in preventing ICU delirium.

This RCT was well-powered and rigorously conducted, so its negative finding tempered early optimism. Possible explanations included the relatively lower-than-expected delirium rate in the control arm (33% vs the 40% anticipated) and the multifactorial nature of delirium (meaning light alone may be insufficient).

New-Generation ICU Lighting Trials

More recent studies have continued to test high-melanopic lighting in ICUs, sometimes with contradictory findings. A 2024 pilot study (ICU Design Working Group) implemented a multi-component ICU room redesign, including a personalized dynamic LED lighting system, in two ICU rooms and compared outcomes to standard rooms.¹⁴

Promising Results from Multi-Component Approach

These promising results, however, come from an observational pilot setup embedded in a bundle of interventions (which included noise reduction and stress-relief measures in addition to lighting).

This makes it hard to isolate the effect of light alone. Still, it underscores the idea that sufficiently intense, well-timed lighting could be a critical piece in delirium prevention when integrated into a holistic ICU care strategy.

Other ICU Lighting Studies

A separate 2025 study by Lucchini et al. examined a new "sky-mimicking" LED lighting technology in a windowless ICU and similarly found no significant impact on delirium.¹⁵ In that prospective non-randomized trial, 5 ICU rooms were outfitted with a blue-enriched dynamic lighting system and 5 rooms kept standard fluorescent lighting.

Eighty-six adult ICU patients were managed under these conditions (intervention vs control rooms). The outcome was again negative: delirium occurred in 15% of patients with the innovative lighting vs 18% under standard lights, a non-significant difference (p=0.78). Sedative usage and long-term psychological outcomes (anxiety, depression, PTSD at follow-up) were also similar.

The authors emphasized that a single intervention (mimicking natural daylight) did not measurably reduce delirium, likely because delirium has multifactorial causes. They suggest that light therapy might need to be part of a broader bundle to show benefit. This concurs with the notion from Simons' RCT that light by itself, while biologically sensible, may not overcome other delirium risk factors unless combined with complementary interventions.

In summary, ICU studies present a mixed picture. Observational data(e.g. window vs no-window rooms, or ICU room upgrades) tend to support that better circadian lighting correlates with less delirium. However, controlled trials of artificial circadian lighting have yielded null results in terms of delirium reduction. These discrepancies could be due to study design differences (e.g. dynamic lighting in isolation vs as part of multi-component changes, or sample size/power issues) and the complexity of delirium's causes.

Studies in Postoperative and General Ward Settings

Beyond the ICU, several studies in surgical and medical inpatient populations have explored light-based interventions for delirium prevention:

Postoperative ICU Patients

Patients recovering from major surgery, especially older adults, are at high risk of delirium (postoperative delirium, POD). Trials of bright light therapy (BLT) in the postoperative period have shown encouraging results. Potharajaroen et al. (2018) conducted a randomized trial in a surgical ICU, assigning 62 post-op patients to receive morning bright light therapy (in addition to standard care) for three days after surgery vs. standard care alone.¹⁶

They found that BLT produced a significant reduction in delirium incidence.Using multivariate analysis, BLT had a preventive effect on delirium independent of other risk factors. Interestingly, patients who received both BLT and supplemental oxygen had the lowest delirium risk – the authors speculated that light improved sleep (as evidenced by lower Insomnia Severity Index scores in the BLT group) while oxygen addressed metabolic factors, and together these targeted two delirium pathways. The BLT group indeed slept better and had more stable acid-base status, correlating with their lower delirium rates.

Acute Care Wards and Postoperative Recovery

Outside the ICU, research has tested whether exposing hospitalized patients to more daytime light (or structured phototherapy) can prevent delirium. A recent meta-analysis (2019) of randomized trials concluded that strategies focusing on sleep and circadian health do help prevent postoperative delirium.¹⁷ In particular, timed bright light exposure was highlighted as effective (pooled analysis showed a significant reduction in POD, p = 0.006).

This aligns with earlier small trials by Taguchi and colleagues, who showed that giving esophageal surgery patients 5,000 lux of light in the morning for several days post-op hastened circadian rhythm recovery, reduced delirium severity, and even enabled earlier mobilization.¹⁸ For example, in one pilot (Taguchi 2007), the BLT group had significantly lower delirium scores by postoperative day 3 and ambulated ~2 days sooner than controls. A follow-up RCT in 2011 similarly found that 2 hours of morning bright light for four days post-esophagectomy tended to lower delirium occurrence and stabilized autonomic function.¹⁹

Elderly Medical Patients with Dementia

Delirium often overlaps with dementia in older patients. A notable trial by Zou et al. (2022) examined light therapy in older adults with Alzheimer's disease-related dementia.²⁰

This population can experience "sundowning" or delirium-like agitation in the evening, which may relate to circadian disruption. Zou et al. tested a 4-week regimen of daily bright light exposure in these patients (likely in a nursing facility or geriatric ward setting) and observed a significant reduction in delirium symptoms compared to controls.

Age-Related Light Sensitivity

Confusion Assessment Method (CAM) scores improved after 2 weeks of light therapy and further by 4 weeks, indicating fewer or less severe delirium episodes. By the end of the trial, the light-treated group had markedly suppressed delirium – essentially, the intervention helped stabilize their circadian biology and cognition. This RCT provides evidence that even in chronic cognitively impaired patients, structured light exposure can mitigate delirium.

General Hospitalized Older Adults

Building on such findings, some hospitals have implemented multicomponent delirium prevention programs for elderly inpatients that include a lighting component. For example, trials in Asia have combined morning phototherapy, increased daytime activity, and sleep hygiene for older patients after surgery. In these studies, patients on the enhanced "living schedule" had significantly lower rates of postoperative delirium, better preservation of cognitive and physical function, and even shorter hospital stays than controls.

The inclusion of scheduled bright light exposure in the daytime was considered a key element of these protocols. Although such interventions bundle several strategies, they align with the idea that maintaining circadian normalcy (through light and sleep management) aids recovery. On the other hand, it's worth noting that research on light therapy in pediatric patients is scant – most evidence to date involves adults, particularly the elderly.

Discussion and Implications

The collective evidence suggests that circadian lighting interventions hold promise for reducing delirium, but their success may depend on proper implementation and combination with other measures. Mechanistically, there is little doubt that light can modulate circadian biology in critically ill patients – studies consistently show effects on melatonin rhythms and sleep parameters. Clinically, ensuring robust daytime light (especially blue-enriched light that strongly stimulates ipRGCs) and preserving darkness at night are sensible goals to mimic normal physiology.

It is important to note that delirium is multifactorial. While light is a key factor in circadian regulation, other contributors (sedative medications, inflammation, pain, noise, etc.) also must be addressed. This likely explains why trials adding light alone (e.g. Simons 2016, Lucchini 2025) didn't move the needle on delirium – any benefit from light may have been offset by other delirium triggers in those environments. In contrast, multi-component interventions (like the 2024 ICU redesign study) or bundled protocols (like those for post-op elders) saw improvements, implying synergy between light and other delirium prevention strategies.

Key Clinical Takeaways

Another consideration is timing and dosage of light. It may be that benefits depend on administering light at the correct circadian phase. For instance, morning light is generally most effective for phase-shifting the clock and promoting alertness; giving bright light later in the day could inadvertently disturb sleep.

Most studies reviewed did focus on daytime or morning exposure (and dimmer evenings), which is consistent with circadian principles.

Implications for Healthcare Workers

In special populations like postoperative patients and those with dementia, light therapy appears particularly beneficial. These groups often have pre-existing circadian vulnerabilities (e.g. the disorientation after anesthesia, or the neurodegeneration of the circadian system in Alzheimer's).

For them, blue-enriched light exposure can be a powerful zeitgeber to recalibrate the body clock after the perturbation of surgery or illness. The evidence of reduced delirium and faster recovery (earlier ambulation, shorter hospital stay) in these contexts is compelling.

New Research Frontiers: Innerscene as a Clinical Research Platform

While the evidence reviewed demonstrates promise for melanopic lighting in clinical settings, most studies have been limited by the technological constraints of conventional LED systems. A new generation of lighting technology may unlock previously impossible research opportunities and finally translate circadian lighting into reliable clinical interventions.

What Makes Next-Generation Circadian Lighting Different?

Most tunable-white luminaires peak at 6,500 K and deliver a melanopic/photopic (M/P) ratio ≈ 1.0, allowing simulation of daylight but never equaling the blue-sky stimulus experienced outdoors. Innerscene's Virtual Sun and Circadian Sky systems use a patented optical architecture—collimators plus multi-reflective glass—to create virtual lighting at optical infinity:

Virtual Sun:
3,200 – 40,000 K range, M/P ratios up to 1.6; creates an "infinite-depth window" effect with a collimated, UV-free solar beam at a fixed angle, with CCT and intensity automatically changing throughout the day based on sunrise/sunset or wall clock scheduling.

Circadian Sky:
2,200 – 40,000 K range with dual-reflection glazing that yields perceptual depth beyond the ceiling plane, enabling realistic zenith-sky blues and warm sunset/candlelight tones.

No other commercial lighting system offers both extreme color temperature headroom (realistic sky blues) and the binocular depth cues that allow eyes to relax on a distant focal plane—two factors that may be critical for clinical effectiveness.

Why Depth Cues Matter

Natural windows consistently outperform flat LED panels in healthcare metrics, yet most lighting trials ignore the geometric component of real daylight. Three strands of emerging evidence suggest that depth perception is not merely aesthetic:

Notably, large RCTs that merely increased CCT and illuminance (e.g., Simons 2016) but maintained flat ceiling designs reported no delirium benefit, despite delivering ≥1,700 lux of 4,300 K light. This suggests that spectral quality alone may be insufficient without appropriate spatial context.

Research Questions Previously Impossible to Address

High-Melanopic Research Without Glare

Previous limitation: Flat panels required raising photopic lux to dangerous levels to achieve high melanopic doses

New opportunity: Advanced systems can deliver ≥1.5 M/P ratios at comfortable illuminances, enabling trials to separate spectral effects from visual discomfort

Visual Accommodation in Critical Care

Previous limitation: Flat luminaires force eyes to focus at ~2 meters; ciliary muscle never relaxes

New opportunity: Optical-infinity imagery allows measurement of accommodation micro-fluctuations, ocular strain, and downstream sympathetic activity

Automated Circadian Programming with Research Control

Previous limitation: Existing dynamic lighting required manual programming and offered limited control for research protocols

New opportunity: Systems can automatically adjust CCT and intensity based on sunrise/sunset or wall clock schedules, while REST APIs enable researchers to implement custom lighting protocols for precise experimental control

True Circadian Contrast

Previous limitation: Most ICUs maintain 50+ lux at night, blunting melatonin responses

New opportunity: Deep-dimming capability plus high daytime M/P ratios enable testing of full circadian contrast (≥300 melanopic lux day / <10 melanopic lux night) without visual discomfort. Additionally, very low CCT settings (2200K) achieve M/P ratios of 0.4, providing circadian-friendly nighttime illumination for safety while preserving melatonin production

Physiological Basis for Enhanced Effectiveness

Several physiological principles support the hypothesis that depth-enhanced circadian lighting may prove more clinically effective: ipRGC Optimization: These cells saturate near 300 melanopic lux; advanced systems can reach this threshold with just ~200 photopic lux, eliminating the glare that hampered earlier trials

Cognitive Engagement: Illusory skies perceived as infinitely distant engage the dorsal visual stream—the brain's spatial-map network—linking lighting interventions to areas involved in attention, arousal, and orientation

Environmental Authenticity:Window studies consistently link daylight exposure to lower delirium rates (21.7% vs 43.3% in windowed vs windowless ICU rooms); advanced lighting can reproduce both spectral and depth qualities of real sky

Proposed Research Directions

ICU Delirium Prevention Trial

Neurocognitive Mechanism Study

Post-Operative Recovery Trial

Why This Research Matters Now

Existing studies hint that spectral tuning alone rarely suffices for clinical benefit—a critical insight given that natural sky light often exceeds 40,000K when measured without direct sunlight exposure, a color temperature that artificial lighting has failed to replicate until recently. When high-quality daylight combines with convincing depth perception, measurable improvements in melatonin alignment, stress reduction, and delirium prevention emerge. Advanced lighting platforms are the first commercially-ready systems to supply both variables at research-grade specifications (40,000 K capability, M/P ratios of 1.6, optical infinity effects).

This technological advancement unlocks experiments that were previously impractical:

Mapping dose-response curves for melanopic light without visual discomfort

Testing whether spatial-cognitive activation translates to measurable clinical outcomes


Quantifying how far-field depth cues influence autonomic balance and sleep in high-acuity settings

Implementing custom lighting protocols via REST APIs for precise experimental control and real-time adjustments

Research Collaboration Opportunity

These next-generation lighting systems do more than emit blue-enriched photons—they restore the complete geometry of an outdoor sky environment. Evidence from window studies, neuroimaging research, and stress-response trials suggests this missing spatial component could be the key to finally transforming circadian lighting into a reliable clinical intervention.

Researchers interested in exploring these opportunities are invited to reach out to Jonathan Clark ([email protected]) to discuss potential collaborations, research protocols, and access to advanced circadian lighting platforms for clinical trials.

Conclusion

Over the last decade substantial progress has been made in understanding and leveraging melanopic light for delirium prevention. Illuminating the ICU (and hospital) environment in a more biologically appropriate way – bright days, dark nights – aligns with our evolving recognition that the ICU should strive to support patients' natural physiology, even in the midst of critical illness.

While not a standalone solution, strategic light modulation is a low-risk, non-pharmacologic tool that can complement other delirium mitigation efforts. Ongoing research is focusing on refining light delivery (intensity, spectrum, timing) and combining it with other interventions for maximum impact. As this field advances, it brings hope that something as simple as adjusting a light switch – guided by the science of ipRGCs and circadian rhythms– can help reduce the burden of ICU delirium and improve patient recovery.

The emergence of next-generation lighting platforms that combine high melanopic output with authentic spatial depth opens new frontiers for clinical research. For the first time, researchers can investigate the synergistic effects of spectral quality and environmental geometry—potentially unlocking the full therapeutic potential of circadian lighting in critical care settings.

References

1. 1. Kim DJ, Moon JY, Kim SM, et al. Association of natural light exposure and delirium according to the presence or absence of windows in the intensive care unit. Acute Crit Care. 2022;37(2):197-203. https://www.accjournal.org/journal/view.php?number=1324
2. 2. Kim DJ, Moon JY, Kim SM, et al. Association of natural light exposure and delirium according to the presence or absence of windows in the intensive care unit. Acute Crit Care. 2022;37(2):197-203. https://www.accjournal.org/journal/view.php?number=1324
3. 3. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(5557):1070-1073. https://en.wikipedia.org/wiki/Intrinsically_photosensitive_retinal_ganglion_cell
4. 4. Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science. 2002;295(5557):1065-1070. https://en.wikipedia.org/wiki/Intrinsically_photosensitive_retinal_ganglion_cell
5. 5. Telias I, Wilcox ME. Sleep and circadian rhythm in critical illness. Crit Care. 2019;23(1):82. doi:10.1186/s13054-019-2366-0. https://link.springer.com/article/10.1007/s00134-022-06656-7
6. 6. Wu L, Sun D, Tan Y. Circadian rhythm disturbance and delirium in ICU patients: a prospective cohort study. BMC Anesthesiol. 2023;23(1):190. doi:10.1186/s12871-023-02147-4. https://pmc.ncbi.nlm.nih.gov/articles/PMC10262569/
7. 7. Kim DJ, Moon JY, Kim SM, et al. Association of natural light exposure and delirium according to the presence or absence of windows in the intensive care unit. Acute Crit Care. 2022;37(2):197-203. https://www.accjournal.org/journal/view.php?number=1324
8. 8. Wu L, Sun D, Tan Y. Circadian rhythm disturbance and delirium in ICU patients: a prospective cohort study. BMC Anesthesiol. 2023;23(1):190. doi:10.1186/s12871-023-02147-4. https://pmc.ncbi.nlm.nih.gov/articles/PMC10262569/
9. 9. Wu L, Sun D, Tan Y. Circadian rhythm disturbance and delirium in ICU patients: a prospective cohort study. BMC Anesthesiol. 2023;23(1):190. doi:10.1186/s12871-023-02147-4. https://pmc.ncbi.nlm.nih.gov/articles/PMC10262569/
10. 10. Wu L, Sun D, Tan Y. Circadian rhythm disturbance and delirium in ICU patients: a prospective cohort study. BMC Anesthesiol. 2023;23(1):190. doi:10.1186/s12871-023-02147-4. https://pmc.ncbi.nlm.nih.gov/articles/PMC10262569/
11. 11. Telias I, Wilcox ME. Sleep and circadian rhythm in critical illness. Crit Care. 2019;23(1):82. doi:10.1186/s13054-019-2366-0. https://link.springer.com/article/10.1007/s00134-022-06656-7
12. 12. Kim DJ, Moon JY, Kim SM, et al. Association of natural light exposure and delirium according to the presence or absence of windows in the intensive care unit. Acute Crit Care. 2022;37(2):197-203. https://www.accjournal.org/journal/view.php?number=1324
13. 13. Simons KS, Laheij RJ, van den Boogaard M, et al. Dynamic light application therapy to reduce the incidence and duration of delirium in intensive-care patients: a randomised controlled trial. Lancet Respir Med. 2016;4(3):194-202. doi:10.1016/S2213-2600(16)00025-4. https://www.thebottomline.org.uk/summaries/icm/dynamic-light-application-therapy-to-reduce-the-incidence-and-duration-of-delirium-in-intensive-care-patients-a-randomised-controlled-trial/
14. 14. Knauert MP, Yaggi HK, Redeker NS, et al. Modification in ICU design may affect delirium and circadian melatonin: a proof of concept pilot study. Intensive Care Med. 2024;50(7):1053-1065. doi:10.1007/s00134-024-07438-x. https://research.uni-luebeck.de/en/publications/modification-in-icu-design-may-affect-delirium-and-circadian-mela
15. 15. Lucchini A, Elli S, Bambi S, et al. Impact of new lighting technology versus traditional fluorescent bulbs on sedation and delirium in the ICU. Minerva Anestesiol. 2025;91(1):1-11. doi:10.23736/S0375-9393.24.18143-X. https://pubmed.ncbi.nlm.nih.gov/39299170/
16. 16. Potharajaroen S, Tangwongchai S, Tayjasanant T, et al. Bright light and oxygen therapies decrease delirium risk in critically ill surgical patients by targeting sleep and acid-base disturbances. Crit Care Med. 2018;46(4):e328-e335. doi:10.1097/CCM.0000000000002926. https://pubmed.ncbi.nlm.nih.gov/29276990/
17. 17. Liu J, Wang L, Chen Y, et al. Application of light in delirium: a bibliometric analysis. Front Neurol. 2025;16:1549396. doi:10.3389/fneur.2025.1549396. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1549396/full
18. 18. Taguchi T, Yano M, Kido Y. Influence of bright light therapy on postoperative patients: a pilot study. Intensive Crit Care Nurs. 2007;23(5):289-297. doi:10.1016/j.iccn.2007.03.006. https://pubmed.ncbi.nlm.nih.gov/17692522/
19. 19. Taguchi T, Yano M, Kido Y. The usefulness of bright light therapy for patients after oesophagectomy. Intensive Crit Care Nurs. 2011;27(3):158-166. doi:10.1016/j.iccn.2011.03.008. https://pubmed.ncbi.nlm.nih.gov/21511473/
20. 20. Liu J, Wang L, Chen Y, et al. Application of light in delirium: a bibliometric analysis. Front Neurol. 2025;16:1549396. doi:10.3389/fneur.2025.1549396. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1549396/full